Related by context. All words. (Click for frequent words.) 77 Allovectin 7 ® 74 Allovectin 7 r 73 Allovectin 7 73 forodesine 72 Panzem R NCD 71 #D#C# 71 lintuzumab SGN 71 YONDELIS 71 MOZOBIL 71 talactoferrin 71 Insegia 71 Bezielle 71 HGS ETR1 70 MAGE A3 ASCI 70 Phase #b/#a clinical 70 AIMM trial 70 telaprevir VX 70 IMA# 70 oral ridaforolimus 69 AEG# 69 ELACYT 69 HGS ETR2 69 otelixizumab 69 phase IIb clinical 69 Phase IIb clinical trials 69 HCD# [002] 69 bardoxolone 69 acyclovir Lauriad R 69 ASONEP 69 Exherin TM 69 Azixa 69 Personalized Immunotherapy 69 FOLOTYN ® 69 TOCOSOL Paclitaxel 69 custirsen 68 OncoVEX GM CSF 68 RhuDex ® 68 HuLuc# 68 Phase IIIb clinical 68 Xanafide 68 HGS# 68 UPLYSO 68 Aflibercept 68 oral prodrug 68 maribavir 68 valopicitabine 68 Omacetaxine 68 Panzem R 68 Archexin 68 OvaRex R 68 PXD# 68 IL# PE#QQR 68 elotuzumab 68 R#/MEM # 68 antibody MAb 68 PDE4 inhibitor 68 HuMax CD4 68 alvespimycin 68 neratinib 68 MAXY G# 68 INCB# [001] 68 vosaroxin 68 Daclizumab 68 Prednisporin 67 PDX pralatrexate 67 successfully commercialize Iluvien 67 cancer immunotherapies 67 initiate Phase 1b 67 Campath ® 67 Azedra 67 mertansine 67 BiovaxID TM 67 phase IIa clinical 67 GALNS 67 CINTREDEKIN BESUDOTOX 67 torezolid phosphate 67 Diamyd ® 67 tezampanel NGX# 67 MKC# MT 67 TransVax tm 67 Traficet EN 67 tubulin inhibitor 67 AnGes 67 EFAPROXYN 67 KNS # 67 Phase Ib II 67 Nanobody 67 Cetrorelix 67 oncolytic virus therapies 67 LEUKINE 67 Civacir 67 PRTX 67 EndoTAG TM -1 67 Canvaxin TM 67 registrational trial 67 CCX# 67 SinuNase TM 67 Phase IIb trials 67 deforolimus 67 Virulizin R 67 novel VDA molecule 67 CEQ# 67 AzaSite Plus 67 CR# vcMMAE 67 Factor VIIa 67 ALN PCS 67 Cloretazine ® 67 huC# DM4 67 TELINTRA 67 PLK1 SNALP 67 forodesine HCl 67 Troxatyl 67 Solazed 67 Urocidin 67 Fibrillex TM 67 BENLYSTA ® 67 Tavocept 67 Onconase 67 HEPLISAV 67 ELND# 67 ularitide 67 DOS# 67 Intravenous CP 67 oral picoplatin 67 bafetinib 67 Clolar ® 66 Alocrest 66 Immunotherapeutic 66 SinuNase 66 SCIB1 66 MAXY alpha 66 PEG PAL 66 ruxolitinib 66 Exelixis compounds 66 valtorcitabine 66 pradefovir 66 GLPG# 66 Phase Ib study 66 Belinostat 66 TYZEKA 66 MEK Inhibitor 66 Viramidine 66 thymalfasin 66 axitinib 66 XYOTAX TM 66 HuMax TAC 66 CMV vaccine 66 Anturol TM 66 faropenem 66 RGB # 66 PSMA ADC 66 drug ISA# 66 investigational humanized monoclonal antibody 66 REMUNE R 66 Cintredekin Besudotox 66 TELCYTA 66 GVAX ® 66 induced macular edema 66 PANVAC VF 66 HepeX B 66 urocortin 2 66 HQK 66 Trofex 66 atacicept 66 Vicinium TM 66 TRO# 66 Surfaxin LS 66 tremelimumab 66 DCVax R Prostate 66 Nexavar ® 66 NPC 1C 66 vaccines oncolytic virus 66 CD# CEA 66 JAK inhibitor 66 Cloretazine 66 Panzem 66 CCR9 antagonist 66 Phase 1b clinical trials 66 oral deforolimus 66 targeted radiotherapeutic 66 Asentar 66 Pimavanserin 66 HGS ETR1 mapatumumab 66 Phase III Pivotal 66 lintuzumab 66 Entereg R 66 Alzhemed TM 66 Phenoptin 66 orally administered inhibitor 66 MGCD# [001] 66 refractory chronic lymphocytic 66 Vaxfectin TM 66 rhFVIIa 66 Virulizin ® 66 Fodosine 66 sorafenib tablets 66 receptor tyrosine kinase inhibitor 66 OvaRex ® MAb 66 anti CD# antibodies 66 Phase Ib 66 confirmatory clinical 66 Shigamabs ® 66 Genasense ® 66 Loramyc R 65 MyVax R 65 pafuramidine 65 Pazopanib 65 ZFP Therapeutics 65 Glufosfamide 65 MORAb 65 eniluracil 65 ACTEMRA TM 65 OPAXIO 65 Ozarelix 65 HuCNS SC 65 Neulasta ® 65 IMiDs 65 BAY #-# 65 Tamibarotene 65 ganetespib 65 pain palliation 65 tamibarotene 65 Vitaxin 65 Golimumab 65 Symadex 65 dirucotide MBP# 65 LymphoStat B belimumab 65 CTAP# Capsules 65 L BLP# 65 PREOS R 65 Phase Ib clinical trials 65 ONCONASE R 65 volociximab 65 candidate AQ4N 65 entinostat 65 ONCONASE 65 ixabepilone 65 TREANDA 65 R sorafenib tablets 65 ThermoDox R 65 CRMD# 65 Imprime PGG 65 REBETOL combination therapy 65 dirucotide 65 Anturol 65 cilengitide 65 LymphoStat B TM 65 adecatumumab 65 Peginterferon alfa 2b 65 ATG Fresenius S 65 LHRH antagonist 65 agonistic human 65 OncoVEX 65 phase IIb trial 65 Selective Electrochemical Tumor Ablation 65 cMET 65 EndoTAG TM 65 TransVax ™ 65 trastuzumab DM1 T DM1 65 velafermin belinostat 65 IMC A# 65 Solazed TM 65 rNAPc2 65 RIGScan CR 65 LEVADEX ™ 65 HspE7 65 Maribavir 65 Aurexis 65 docetaxel Taxotere ® 65 Canvaxin 65 MEK inhibitor 65 IRX 2 65 ospemifene 65 PHX# 65 XL# anticancer compounds 65 Icatibant 65 Bicifadine 65 mapatumumab 65 Azedra ™ 65 AQ4N 65 Onalta ™ 65 cannabinor 65 Octreolin 65 Generx 65 Stedivaze 65 investigational monoclonal antibody 65 THR beta agonist 65 evaluating tivozanib 65 tezampanel 65 recurrent metastatic ovarian cancer 65 Neulasta R 65 XP# XP# 65 NP2 Enkephalin 65 MBP# [001] 65 XmAb# 65 MVA BN 65 erlotinib Tarceva ® 65 investigational therapies 65 Trofex TM 65 Initiate Clinical Trial 65 hypoxia activated prodrug 65 OncoGel 64 Azedra TM 64 NEUMUNE 64 AVN# [001] 64 MCSP respectively 64 ganaxolone 64 Neo Urinary Conduit 64 Amigal 64 pralatrexate 64 autoimmune indications 64 Amrubicin 64 Anthim 64 personalized immunotherapy 64 PEGylated interferon beta 1a 64 Cethromycin 64 HuMax EGFr 64 Fludara ® 64 Pivotal Phase III 64 PEG SN# 64 CoFactor 64 RELOVAIR ™ 64 TRISENOX 64 TBC# 64 TOCOSOL Camptothecin 64 Velcade bortezomib 64 RNAi therapeutic targeting 64 vidofludimus 64 DPX Survivac 64 Pradefovir 64 StemEx R 64 MyVax ® 64 Granulocyte Colony Stimulating Factor 64 tolevamer 64 EndoTAGTM 1 64 Clavis Pharma 64 XL# XL# XL# XL# 64 MYDICAR 64 ulimorelin 64 Oral NKTR 64 CB2 selective receptor agonist 64 oral antiviral 64 PrevOnco 64 Phase 2b Clinical Trial 64 Perifosine 64 Quinamed 64 vernakalant oral 64 CBLC# 64 GVAX R 64 midstage studies 64 initiated Phase 1b 64 MYDICAR ® 64 voclosporin 64 ongoing Phase IIIb 64 generation URAT1 inhibitor 64 BioNumerik 64 phase Ib 64 StemEx 64 Initiates Enrollment 64 Raptiva ® 64 Protexia R 64 Phase 2a clinical trials 64 MGd 64 Zemiva ™ 64 ALTROPANE 64 EP #R 64 Initiates Clinical 64 visilizumab 64 confirmatory Phase III 64 Phase IIa clinical trials 64 registrational studies 64 EOquin 64 omega interferon 64 darapladib 64 G#DT 64 LBH# 64 ORENCIA R 64 Prednisporin TM 64 IMC #B 64 LEP ETU 64 orBec 64 IIa trial 64 telomerase therapeutic 64 galiximab 64 PNP inhibitor 64 phase IIa 64 Alferon N 64 Altastaph 64 regadenoson 64 Evoltra ® 64 Trastuzumab DM1 64 Myocet 64 Cx# [002] 64 motesanib 64 CAMPATH 64 zanolimumab 64 PEGylated Fab fragment 64 Telatinib 64 Pafuramidine 64 Adnectin 64 GLP toxicology studies 64 tramiprosate Alzhemed TM 64 Pralatrexate 64 catheter occlusion 64 StaphVAX R 64 Memryte 64 UVIDEM 64 gefitinib Iressa 64 enzastaurin 64 subcutaneous formulation 64 Ramoplanin 64 Nuvion 64 eTag assays 64 PGL# 64 TACI Ig 64 aflibercept 64 docetaxel Taxotere R 64 HCV protease inhibitors 64 Hsp# Inhibitor 64 BHT DNA 64 epigenetic therapies 64 lomitapide 64 oral proteasome inhibitor 64 TransVax TM 64 dacetuzumab 64 CYT# potent vascular disrupting 64 Romidepsin 64 Lenocta 64 Sebivo 64 Achieves Primary Endpoint 64 treatment naïve genotype 64 squalamine 64 Tarceva TM 64 LUCASSIN 64 rindopepimut 64 synthetic retinoid 64 JVRS 64 MT#/MEDI-# 64 registrational 64 Urocidin TM 64 JAK inhibitors 64 triphendiol 64 tiapamil 64 Laquinimod 64 Phase Ib IIa 64 Aviptadil 64 XL# XL# 64 non nucleoside HCV 64 Palifosfamide 64 ATL# [001] 64 includes TOLAMBA TM 64 Dacogen decitabine 64 Phase Ib clinical 64 oral taxane 64 Vectibix panitumumab 64 elacytarabine 64 Androxal ® 64 therapeutic monoclonal antibody 64 TOLAMBA 64 Chrysalin 64 Nanobody ® 64 GAMMAGARD 64 P#X# antagonist 64 CD# antibody [001] 64 SAR# [004] 64 rALLy clinical trial 64 albinterferon alfa 2b 64 oral methylnaltrexone 63 radiation sensitizer 63 Genz # 63 including eniluracil ADH 63 Dacogen injection 63 Xcytrin R 63 BioVant 63 ocular formulation 63 Zerenex ™ 63 daclizumab 63 castrate resistant prostate cancer 63 huN# DM1 63 omacetaxine 63 BLA filing 63 TroVax ® 63 AeroLEF TM 63 velafermin 63 depsipeptide 63 cMET inhibitor 63 RAPTIVA 63 JAK1 63 sodium thiosulfate STS 63 oral salmon calcitonin 63 paclitaxel poliglumex 63 Darinaparsin 63 glufosfamide 63 generation purine nucleoside 63 MEK inhibitors 63 ANYARA 63 MKC# MKC# PP 63 CCR5 mAb 63 ALN RSV# 63 Initiate Phase 63 ponatinib 63 TRISENOX ® 63 PrevOnco ™ 63 Aryplase 63 teplizumab 63 Amplimexon 63 Tesmilifene 63 oncology indications 63 clinical trials dacetuzumab SGN 63 isoform selective 63 SNT MC# 63 Tesetaxel 63 unresectable stage 63 Aganocide 63 ZADAXIN ® 63 GW# [003] 63 BLA submission 63 ONTAK 63 multicenter Phase II 63 EVIZON TM 63 JZP 63 Zelrix 63 Cellegesic 63 ChimeriVax JE 63 HepeX B TM 63 CIMZIA TM 63 terlipressin 63 elvucitabine 63 OXi# 63 SUCCEED trial 63 candidate REP# 63 Sapacitabine 63 Targeted Chemotherapy 63 humanized anti 63 Pruvel 63 TLK# 63 danoprevir 63 celgosivir 63 placebo intravenously 63 AVONEX ® 63 budesonide foam 63 Cethrin 63 MT# MEDI 63 multicenter Phase 63 Excellagen 63 ZOLINZA 63 Copegus R 63 lumiliximab 63 GTC recombinant human 63 Randomized Phase 63 Shigamabs R 63 ARRY # 63 proteasome inhibitor 63 Multimeric 63 EOquin TM 63 IgG1 monoclonal antibody 63 MOVIPREP R 63 reslizumab 63 NGX# 63 Seliciclib 63 sumatriptan DosePro 63 Telintra 63 molecular imaging radiopharmaceutical 63 JOULFERON 63 IMPDH inhibitor 63 incyclinide 63 Numax 63 GRNVAC1 63 Phase IIa trials 63 LibiGel ® 63 IAP inhibitors 63 CCX# B 63 Vivecon 63 Fabry Disease 63 ALN TTR 63 IAP inhibitor 63 Valortim 63 SPRYCEL ® 63 ZALBIN 63 Universal Flu Vaccine 63 HuMax CD# 63 interferon gamma 1b 63 tivozanib 63 apaziquone 63 Reverset 63 Aplidin 63 StaphVAX 63 pertuzumab 63 antiangiogenesis therapies 63 Lucanix R 63 JP-#/fipamezole 63 Chemophase 63 PRT# 63 anti CD3 monoclonal 63 Interferon alpha 63 initiate Phase IIb 63 Elagolix 63 Pivotal Phase 63 Ocrelizumab 63 ZADAXIN 63 Zemiva TM 63 BCR ABL inhibitors 63 Meets Primary Endpoint 63 DCVax R 63 ® bortezomib 63 Gemzar ® 63 bosutinib 63 CORT # 63 Angiocept 63 Ofatumumab 63 ZEFTERA TM Zevtera TM 63 Sym# 63 Excellarate TM 63 NVA# 63 Inhalation Solution 63 PROSTVAC VF 63 RhuDex 63 cinacalcet HCl 63 Filgrastim 63 RAPTIVA R 63 Protexia ® 63 Vidaza R 63 #I TM# 63 DAVANAT ® 63 Phase III Clinical Trials 63 OMNARIS HFA 63 Zensana TM 63 HCl Tablets 63 PEG Interferon lambda 63 Vascugel 63 relapsed multiple myeloma 63 pitavastatin 63 treatment naive genotype 63 Onco TCS 63 ocrelizumab 63 Annamycin 63 Chimigen TM 63 Actimmune ® 63 Pivotal Trial 63 THALOMID 63 ALN TTR# 63 nucleotide analog 63 pomalidomide 63 Curaxin 63 PREVENAR 63 Exelixis XL# 63 Successfully Completes Phase 63 octreotide implant 63 DermaVir Patch 63 vemurafenib 63 Phase 1b trial 63 PD LID 63 NV1FGF 63 Kuvan R 63 Curaxin CBLC# 63 OMP #M# 63 IFN Beta CTP 63 Syncria 63 Initiates Phase II 63 MVA BN R 63 immunological diseases 63 Cimzia TM 63 SEBIVO 63 Phase III HEAT 63 vorinostat 63 IV Busulfex 63 Neuradiab 63 Apaziquone 63 HepaSphere 63 CytoFab 63 virus HCV protease inhibitor 63 randomized Phase 2b 63 hepatitis C HCV 63 cystinosis patients 63 LymphoStat B 63 ZYBRESTAT fosbretabulin 63 CDP# 63 Generx TM 63 Somatuline R Autogel R 63 Leukine 63 Phase IIB 63 MDV# 63 Ixempra 63 TRAIL receptor antibodies 63 MAA submission 63 product candidate Lpathomab 63 relapsed leukemia 63 GEM OS2 63 anticancer agent 63 Advexin 63 WILEX 62 class mGluR5 inhibitor 62 sapacitabine 62 FavId 62 lorvotuzumab mertansine 62 ongoing Phase 1b 62 Evoltra TM 62 GED aPC 62 Vilazodone 62 FluCide 62 H#N# VLP vaccine 62 pegylated interferons 62 Phase #b/#a 62 KIACTA ™ 62 Bioral Amphotericin B 62 alemtuzumab Campath 62 HER2 positive metastatic breast 62 YONDELIS R 62 candidate deforolimus 62 STELARA TM 62 Marqibo 62 Clofarabine 62 immunotherapeutic vaccine 62 AzaSite Xtra 62 ridaforolimus 62 ALN VSP 62 NeuroVax TM 62 riociguat 62 dose cohort 62 lesinurad 62 HRPC 62 BRIM2 62 EGRIFTA TM 62 Ophena TM 62 Oracea TM 62 lymphoid malignancies 62 Tezampanel 62 Aplidin R 62 Myrexis 62 OMAPRO 62 ZK EPO 62 REOLYSIN ® 62 Behcet uveitis 62 AP# [003] 62 Mpex 62 vilazodone 62 histone deacetylase HDAC inhibitor 62 TKM ApoB 62 novel therapeutic antibodies 62 HepaGam B 62 Corgentin 62 Carfilzomib 62 RNAi therapeutic 62 MyVax 62 PEP# [003] 62 PRECISE Trial 62 Soliris TM eculizumab 62 Corlux 62 metastatic castration resistant 62 Nicole Onetto MD 62 paclitaxel Taxol ® 62 TMC# [002] 62 Dyloject TM 62 Cloretazine R VNP#M 62 nonclinical studies 62 VitiGam 62 sodium glucose cotransporter 62 VitiGam TM 62 ROTATEQ 62 Æterna Zentaris 62 refractory gout 62 Targretin 62 Iluvien ® 62 BRAF V# mutation 62 Proxinium TM 62 TORISEL 62 Multiferon R 62 OHR/AVR# 62 anti EGFR antibody 62 PORxin TM 62 AEGR 62 Dual Opioid 62 Cinryze TM 62 Vandetanib 62 immatics 62 tanespimycin 62 DR Cysteamine 62 immunotherapeutic approaches 62 systemic ALCL 62 Copegus ribavirin 62 dasatinib Sprycel 62 Loramyc TM 62 refractory Hodgkin lymphoma 62 NovaDel 62 methylnaltrexone 62 Cardio Vascu Grow 62 Xcellerated T Cells 62 DU #b 62 satraplatin 62 AzaSite TM 62 PRECISE trial 62 Dalbavancin 62 Pirfenidone 62 Veronate 62 Fx #A 62 TRIOLEX HE# APOPTONE HE# 62 Metastatic Melanoma 62 Kosan dependence 62 NeoLipid R 62 BENLYSTA 62 investigational compounds 62 nicotinic alpha 7 62 Maxy G# 62 PI3K/Akt pathway inhibitor 62 CCR5 antagonist 62 mocetinostat MGCD# 62 Hematide ™ 62 Xeloda ® 62 TransVax 62 RECOTHROM R 62 belinostat 62 Phase 2a trial 62 IMGN# 62 mifamurtide 62 MSCRAMM 62 antisense drug 62 Genasense ® oblimersen 62 Alfacell proprietary ribonuclease 62 NEUGENE antisense 62 dalbavancin 62 Androxal TM 62 eltrombopag 62 TPI ASM8 62 AVP #D# 62 Mepact 62 LE DT 62 metastatic sarcomas 62 metastatic hormone refractory 62 RDEA# 62 clinical trials SGN 62 Plicera 62 INTEGRILIN R eptifibatide Injection 62 Alemtuzumab 62 Acute Radiation Syndrome ARS 62 DCVax ® Brain 62 Hepatocellular Carcinoma HCC 62 Ketotransdel 62 Japanese Encephalitis vaccine 62 virus HCV infection 62 Varespladib 62 Zerenex 62 CD# monoclonal antibody 62 PS# [001] 62 MGN# 62 immunotherapeutic agent 62 mipomersen 62 beta 1a 62 Tß4 62 personalized dendritic cell 62 Kepivance 62 low dose cytarabine 62 RG# [001] 62 CONBRIZA 62 BEMA Buprenorphine 62 glucokinase activator 62 Cannabinor 62 Completes Patient Enrollment 62 metastatic neuroendocrine tumors 62 eritoran 62 inhaled AAT 62 Marqibo TM 62 SECTA therapy 62 zileuton CR 62 elagolix 62 Entereg TM 62 CA9 SCAN 62 Neupogen ® 62 Phase IIb Trial 62 ThermoDox ® clinical 62 AZILECT ® 62 Vidaza azacitidine 62 drug pipeline TAFA# 62 Telik logo TELINTRA 62 CRD5 62 ENRICH trial 62 Tectin TM 62 HERmark 62 dacetuzumab SGN 62 relapsed MM 62 BCX# 62 SinuNase ™ 62 relapsing remitting MS RRMS 62 dextofisopam 62 Arikace 62 Topical Interferon Alpha 2b 62 Tarvacin TM 62 Onalta TM 62 indibulin 62 Lenocta TM 62 dimebon latrepirdine 62 Vaxfectin 62 VIVITROL ® 62 Alnylam #x# 62 vaginally administered lidocaine 62 CD3 monoclonal antibody 62 Sulonex TM 62 SCH # 62 Multiferon ® 62 Proellex TM 62 amrubicin 62 Micromet proprietary BiTE 62 Aurora kinase inhibitor 62 Cleviprex TM clevidipine 62 TAXUS TM 62 VALSTAR TM 62 Bronchitol 62 Urokinase 62 Pertuzumab 62 Campath alemtuzumab 62 AZILECT R 62 Talabostat 62 Bioral 62 DCVax R Brain 62 systemically administered 62 AeroLEF R 62 Ceflatonin 62 TKB# 62 clofarabine 62 cintredekin besudotox 62 IND submission 62 Temsirolimus 62 MEPACT 62 HCV SPRINT 62 TRANSDUR Sufentanil 62 Cinryze ™ 62 Phase 2b trial 62 Besivance 62 ionotropic glutamate receptor antagonists 62 BEXXAR 62 BioSTAR R 62 Tarvacin Anti Cancer 62 IV APAP 62 SUPPRELIN R LA 62 Ceflatonin R 62 DXL# 62 Syntonix 62 Azixa ™ 62 phase IIb 62 Panitumumab 62 Bafetinib 62 ENMD # 62 ApoB SNALP 62 CIMZIA ™ 62 eprotirome 62 Acetavance TM intravenous acetaminophen 62 generation NNRTI 62 bortezomib Velcade 62 FOLFOX6 chemotherapy regimen 62 Hedgehog antagonist 62 Septin9 62 BCR ABL inhibitor 62 Phase 1a clinical 62 thetreatment 62 DAVANAT R 62 BZL# 62 Advaxis Phase 62 trastuzumab DM1 62 Vaxfectin ® 62 Dapagliflozin 62 BiovaxID 62 rhMBL 61 pegylated interferon alfa 2a 61 orally bioavailable 61 Zenvia ™ 61 Tyrima 61 Irinotecan 61 Plenaxis R 61 VivaGel TM 61 AZD# 61 JAK2 inhibitor 61 polymerase inhibitors 61 Xyfid TM 61 Phase #b/#a trial 61 treat chronic sinusitis 61 rxRNA 61 HDAC Inhibitor 61 Vidofludimus 61 luliconazole 61 prostone 61 TYGACIL 61 LY# [003] 61 Viprinex 61 GSK# [002] 61 nalbuphine ER 61 Epratuzumab 61 sorafenib Nexavar 61 Zoraxel 61 HCV protease inhibitor 61 MPS IVA 61 chemotherapy induced neutropenia 61 Phase IIb Clinical Trial 61 R roscovitine 61 NEUGENE 61 Dupuytren Contracture 61 samalizumab 61 YERVOY 61 selective orally bioavailable 61 hoFH 61 IoGen